← Organogenesis Holdings Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Available to Common Stockholders, Basic | ($14.8m) |
($4.4m)
+69.96%
|
($64.8m)
-1361.45%
|
($41.1m)
+36.61%
|
$17.9m
+143.67%
|
$94.9m
+428.73%
|
$15.5m
-83.63%
|
$4.9m
-68.16%
|
($937k)
-118.95%
|
$20.0m
+2236.82%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($209k) | ($2.1m) | ($64.8m) | ($40.5m) | $17.9m | $94.9m | $15.5m | $4.9m | $861k | $37.0m | — | |
| Depreciation, Depletion and Amortization | $5.7m | $3.6m | $3.3m | $3.4m | $3.7m | $5.8m | $5.8m | $10.4m | $13.6m | $15.3m | $33.0m | |
| Amortization of Intangible Assets | $1.6m | $2.0m | $3.7m | $6.0m | $3.7m | $4.9m | $4.9m | $4.9m | $3.4m | $3.3m | — | |
| Deferred Income Tax Expense (Benefit) | — | ($7.3m) | $186k | $111k | $112k | ($32.0m) | $2.0m | $2.0m | ($10.7m) | $9.5m | $41.8m | |
| Share-based Payment Arrangement, Noncash Expense | — | — | $1.1m | $936k | $1.7m | $3.9m | $6.6m | $9.0m | $10.6m | $13.3m | $14.1m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | $737k | $648k | $332k | $1.2m | $1.9m | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $1.7m | |
| Nonoperating Income (Expense) | — | — | ($13.2m) | ($10.8m) | ($8.9m) | ($9.1m) | ($2.0m) | ($2.1m) | ($1.5m) | $2.3m | — | |
| Other Nonoperating Income (Expense) | — | — | $162k | $13k | $97k | ($13k) | ($13k) | $57k | $20k | ($5k) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | $7.1m | $4.7m | $18.8m | $28.7m | $8.8m | ($5.5m) | $31.8m | $115.8m | $17.3m | |
| Increase (Decrease) in Inventories | — | — | $5.0m | $11.1m | $6.7m | $9.3m | $9.4m | $8.2m | $6.2m | $17.9m | ($13.8m) | |
| Increase (Decrease) in Accounts Payable | — | — | ($60k) | $4.7m | ($635k) | $3.8m | $3.3m | ($108k) | ($2.4m) | ($528k) | ($3.6m) | |
| Net Cash Provided by (Used in) Operating Activities | ($562k) |
($587k)
-4.33%
|
($60.7m)
-10254.34%
|
($33.5m)
+44.80%
|
$6.8m
+120.28%
|
$62.0m
+811.31%
|
$24.9m
-59.89%
|
$30.9m
+24.37%
|
$14.2m
-54.04%
|
($10.3m)
-172.56%
|
$32.0m
+410.15%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.4m | $2.4m | $1.9m | $6.0m | $21.1m | $31.2m | $33.9m | $24.4m | $10.0m | $14.2m | ($11.1m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($9k) | ($8k) | ($1.2m) | ($146k) | ($201k) | ($1.4m) | ($4.5m) | ($235k) | ($1.1m) | ($188k) | $539k | |
| Net Cash Provided by (Used in) Investing Activities | ($310.0m) | ($14.9m) | ($1.9m) | ($6.2m) | ($24.8m) | ($31.2m) | ($33.9m) | ($24.4m) | ($10.0m) | ($14.2m) | ($11.1m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | ($2.1m) | ($1.9m) | — | ($1.9m) | — | — | ($215k) | — | — | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | $0 | $0 | $25.5m | — | — | |
| Proceeds from Issuance of Common Stock | $303.8m | — | — | $50.3m | $64.7m | — | $0 | $0 | $120.7m | — | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $311.5m |
($328k)
-100.11%
|
$81.6m
+25022.92%
|
$78.7m
-3.57%
|
$42.5m
-46.06%
|
($1.0m)
-102.44%
|
($2.2m)
-112.26%
|
($5.5m)
-150.34%
|
$27.6m
+602.03%
|
($17.4m)
-162.81%
|
($47.7m)
-174.95%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $659k | $500k | $19.0m | $39.0m | $24.4m | $29.7m | ($11.2m) | $1.0m | $31.8m | ($41.8m) | $46.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $659k | $500k | $21.4m | $60.4m | $84.8m | $114.5m | $103.3m | $104.3m | $136.2m | $94.3m | $46.8m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | $221k | $119k | $269k | $2.8m | $2.2m | $2.1m | $0 | $1.2m | $157k | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $4.0m | $5.7m | $7.6m | $8.1m | $9.6m | $5.8m | $2.6m | $5.4m | $5.0m | — | — | |
| Income Taxes Paid, Net | $29k | $96k | $8k | $49k | $61k | $607k | $1.2m | $3.1m | $7.0m | $5.3m | — | |
| Additional Financial Items | ||||||||||||
| Accretion Expense | — | — | $0 | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Termination of Lease | — | — | — | — | — | — | $0 | ($559k) | $0 | — | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | $2.2m | — | — | — | — | — | — | |
| Goodwill | — | — | $25.5m | $25.5m | $28.8m | $28.8m | $28.8m | $28.8m | $28.8m | $28.8m | $1.7m | |
| Income Tax Expense (Benefit) | — | ($7.3m) | $84k | $150k | $530k | ($31.1m) | $4.8m | $5.4m | ($3.7m) | $9.9m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $1.5m | ($2.3m) | — | |
| Investment Income, Interest | — | $2.5m | $64k | — | — | — | — | — | — | — | — | |
| Operating Costs and Expenses | — | — | — | — | — | — | — | — | — | $137.5m | — | |
| Operating Expenses | $209k | $4.6m | $176.2m | $214.5m | $223.6m | $280.9m | $323.6m | $314.1m | $367.6m | $519.5m | — | |
| Operating Lease, Expense | — | — | $2.8m | $6.2m | $6.5m | — | — | — | — | — | — |